Testing whether remote nurse monitoring works like in-person checks
Part of Cancer, Digestive system clinical trials.
This Phase 2 study compares two ways of checking your cancer follow-up: a doctor or nurse visits in person versus remote monitoring by phone and imaging. The goal is to see whether remote monitoring can safely replace or match in-person care for certain low-risk cancers and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a cancer confirmed by tissue biopsy (anatomopathology) within the last 12 months
- You are 18 years old or older
- You have one of these specific conditions: desmoid fibromatosis (abdominal wall), early testicular seminoma, early non-seminoma germ cell tumor, low-risk relapse risk GIST after surgery, certain rare operated gynecologic tumors, operated low-grade glioma, or a low-grade neuroendocrine tumor treated with surgery only
- You can give consent to join the study
- You can safely do the imaging tests needed for follow-up (no imaging-related medical restrictions)
- You have a phone available for follow-up calls
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a specific treatment approach works better for men with higher-risk non-seminomatous germ-cell tumors that have spread. Doctors will use tumor marker changes and where the cancer started (often the chest area) to help guide treatment choices.
This study looks at how to manage germ cell tumors in children and young adults using careful monitoring for some patients and chemotherapy for others. It aims to see whether these approaches can control the cancer while avoiding unnecessary treatment when possible.
This trial tests whether a blood test called miRNA-371 can detect active germ cell tumors in patients who have had surgery or are being watched. It may help guide treatment decisions without needing extra biopsies or scans.
This study looks at how people with testicular cancer are doing after finishing treatment. It mainly focuses on follow-up visits (surveillance) and whether you are in remission, which can help doctors understand and improve post-treatment care.
This study tests a new way of monitoring patients with advanced breast cancer who are already taking hormone therapy and a CDK4/6 inhibitor. The goal is to see if remote monitoring can improve care and quality of life.
This study looks at whether a simple blood test (liquid biopsy) can help track germ cell tumors (testicular cancer). It may help doctors understand your disease better and guide your care.
Hear when a new Gastrointestinal Stromal Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.